Press Releases about Atai Life Sciences N.V.
Rising Number of Mental Health Disorders Fuel Advancing Initiatives to Reduce Psychiatric and Neurological Conditions
March 08, 2022
Topics
Economy
Exposures
Economy
Psychedelic Therapies Offer Hope for Mental Health
March 02, 2022
Psychedelic Therapies Offer Hope for Mental Health
March 02, 2022
Psilocybin and MDMA Get the Green Light for Medical Use in Canada
January 19, 2022
A Recap of How Psychedelics Fared in 2021
January 07, 2022
Use of Ketamine for Mental Disorders Rising While New Therapies Emerge
November 17, 2021
NetworkNewsAudio – Tryp Therapeutics Inc. (CSE: TRYP) (OTCQB: TRYPF) Bringing Therapeutic Options to Diseases with Unmet Needs
September 30, 2021
Topics
Cannabis
Exposures
Cannabis
Psychedelics Renaissance Underway as Paradigm Shifting Cure for Depression Potentially Discovered
September 28, 2021
Topics
Law Enforcement
Exposures
Legal
Investors Turning to Psychedelic Market as Renaissance Continues into New Wave of Diseases
September 27, 2021
Topics
Cannabis
Exposures
Cannabis
Ketamine’s Potential As A Treatment For Depression Has Drawn Major Industry Attention
October 27, 2021
Exposures
Product Safety
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.